Nanogen evaluating microarray business options

NEW YORK, Sept 17 (Reuters) - Nanogen Inc NGEN.O, a maker of advanced diagnostic systems, said on Monday it was exploring options regarding its microarray business, including a possible sale or closure of the unit.

Nanogen hired Credit Suisse to help evaluate alternatives, which might also include a partnership deal.

The goal of the strategic evaluation is to create a restructured business that can reach profitability faster, Nanogen said. (Reporting by Bill Berkrot)